Synthetic cannabinoids are a class of drugs designed to have similar structures and biological activities as the psychoactive components in cannabis. This encompasses a wide range of structural variants, and their potencies and toxicities are not fully understood. This trade publication piece summarizes the history of synthetic cannabinoids and highlights the ongoing challenge they present to public health and interdiction efforts.
Downloads
Similar Publications
- Beyond Adverse Childhood Experiences: What Should be Considered for Trauma-Focused Adolescent Mental Health Risk Assessments?
- ANSI/ASTM E3307-24 Standard Practice for the Collection and Preservation of Organic Gunshot Residue (OGSR)
- Development of Presumptive and Confirmatory Analytical Methods for the Simultaneous Detection of Multiple Improvised Explosives